SKHY Gives Back Its Rebound as the Nasdaq Premium Narrows Into Earnings

The Give-Back

$SKHY is down 6.28% to $163.30 over five hours, and there is no company-specific headline behind it. This is the third act of a violently two-sided week: SK Hynix's Seoul-listed shares posted their worst session on record days after the Nasdaq debut, then the ADR rebounded 14% into July 21 as the broader chip complex bid. Today's slide is the give-back — profit-taking on a name that has been printing double-digit moves on back-to-back sessions, not a reaction to fresh operating data.

The one rumor that could have moved fundamentals — that SK Hynix was negotiating to buy Intel's Ohio fab for U.S. memory production — was denied by the company in a July 21 exchange filing. That took a speculative catalyst off the table rather than adding a real one.

The Premium Is Doing the Talking

The detail that makes this perp legible is the ADR premium. SKHY tracks SK Hynix's Nasdaq-listed American depositary share, and that ADS still trades roughly 30% above the Seoul-listed 000660 common — an implied Korea-equivalent value near $119 against a ~$163 ADR. That gap ballooned toward 50% at the July 10 debut, when U.S. investors got direct access to the name for the first time, and it has been grinding lower since as arbitrage does its work.

So a meaningful chunk of today's move isn't about memory fundamentals at all — it's a rich U.S. listing mean-reverting toward its home market, amplified by a thin post-IPO float and by Korean leverage unwinding, with leveraged fund assets falling from roughly $53B in late June to about $28B by mid-July. When this perp slides on no news, premium compression is often what you're actually watching.

The July 29 Binary

Everything routes into Q2 earnings on July 29. Micron's record guide already repriced the memory complex higher and set a bar SK Hynix now has to clear as the world's largest HBM supplier. The catch: sell-side estimates put Q2 operating profit near 60.4 trillion won — roughly 8% under the ~65 trillion won consensus — and full-scale HBM4 mass production has slipped to the third quarter.

That is the tension a ~30% premium has to justify: a stock priced for acceleration that the near-term numbers may not yet confirm. The print is the single variable that decides whether the U.S. premium holds or converges toward Seoul, and it is the thing that matters most for where this perp sits next week.